-
Symbol
-
PTIX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
240K shares
-
Security Ownership
-
3.41%
Armistice Capital, LLC ownership in Protagenic Therapeutics, Inc.\new Common Stock, par value $0.0001 per share (PTIX)
2025-02-14 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 240K shares of Protagenic Therapeutics, Inc.\new Common Stock, par value $0.0001 per share (PTIX).
This represents 3.41% percent ownership of the company.